Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs AUROBINDO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA AUROBINDO PHARMA ALEMBIC PHARMA/
AUROBINDO PHARMA
 
P/E (TTM) x 41.6 12.6 329.4% View Chart
P/BV x 2.2 1.1 205.5% View Chart
Dividend Yield % 1.7 2.0 85.1%  

Financials

 ALEMBIC PHARMA   AUROBINDO PHARMA
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-22
AUROBINDO PHARMA
Mar-22
ALEMBIC PHARMA/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0901,064 102.5%   
Low Rs672584 115.0%   
Sales per share (Unadj.) Rs269.9400.3 67.4%  
Earnings per share (Unadj.) Rs26.245.7 57.4%  
Cash flow per share (Unadj.) Rs40.864.9 62.9%  
Dividends per share (Unadj.) Rs10.009.00 111.1%  
Avg Dividend yield %1.11.1 103.9%  
Book value per share (Unadj.) Rs266.5419.4 63.5%  
Shares outstanding (eoy) m196.56585.94 33.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.32.1 158.6%   
Avg P/E ratio x33.618.0 186.3%  
P/CF ratio (eoy) x21.612.7 170.1%  
Price / Book Value ratio x3.32.0 168.3%  
Dividend payout %38.119.7 193.6%   
Avg Mkt Cap Rs m173,172482,799 35.9%   
No. of employees `000NANA-   
Total wages/salary Rs m11,33034,509 32.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m53,058234,555 22.6%  
Other income Rs m5053,226 15.7%   
Total revenues Rs m53,563237,781 22.5%   
Gross profit Rs m8,74142,566 20.5%  
Depreciation Rs m2,86811,265 25.5%   
Interest Rs m177486 36.5%   
Profit before tax Rs m6,20134,040 18.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,0457,256 14.4%   
Profit after tax Rs m5,15726,784 19.3%  
Gross profit margin %16.518.1 90.8%  
Effective tax rate %16.821.3 79.0%   
Net profit margin %9.711.4 85.1%  
BALANCE SHEET DATA
Current assets Rs m29,748181,227 16.4%   
Current liabilities Rs m18,30681,560 22.4%   
Net working cap to sales %21.642.5 50.8%  
Current ratio x1.62.2 73.1%  
Inventory Days Days1125 42.1%  
Debtors Days Days662 8.9%  
Net fixed assets Rs m42,554155,104 27.4%   
Share capital Rs m393586 67.1%   
"Free" reserves Rs m51,982245,174 21.2%   
Net worth Rs m52,375245,760 21.3%   
Long term debt Rs m02,492 0.0%   
Total assets Rs m72,302336,331 21.5%  
Interest coverage x36.071.0 50.7%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.70.7 105.2%   
Return on assets %7.48.1 91.0%  
Return on equity %9.810.9 90.3%  
Return on capital %12.213.9 87.6%  
Exports to sales %43.831.1 141.1%   
Imports to sales %12.711.9 106.4%   
Exports (fob) Rs m23,25172,862 31.9%   
Imports (cif) Rs m6,72827,965 24.1%   
Fx inflow Rs m23,25177,245 30.1%   
Fx outflow Rs m6,72831,524 21.3%   
Net fx Rs m16,52345,721 36.1%   
CASH FLOW
From Operations Rs m5,52450,165 11.0%  
From Investments Rs m-3,720-32,116 11.6%  
From Financial Activity Rs m-2,174-29,693 7.3%  
Net Cashflow Rs m-370-11,674 3.2%  

Share Holding

Indian Promoters % 69.1 48.8 141.7%  
Foreign collaborators % 0.5 3.1 16.6%  
Indian inst/Mut Fund % 17.9 38.0 47.1%  
FIIs % 5.3 21.4 24.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 48.2 63.1%  
Shareholders   103,811 358,459 29.0%  
Pledged promoter(s) holding % 0.0 15.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   CIPLA    DR. REDDYS LAB    SUN PHARMA    LUPIN    PIRAMAL ENTERPRISES    


More on ALEMBIC PHARMA vs Aurobindo Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALEMBIC PHARMA vs Aurobindo Pharma Share Price Performance

Period ALEMBIC PHARMA Aurobindo Pharma S&P BSE HEALTHCARE
1-Day 1.89% -0.43% -0.89%
1-Month -3.94% -15.24% -1.85%
1-Year -26.80% -34.62% -6.83%
3-Year CAGR 2.72% 0.81% 20.56%
5-Year CAGR 3.09% -7.35% 10.73%

* Compound Annual Growth Rate

Here are more details on the ALEMBIC PHARMA share price and the Aurobindo Pharma share price.

Moving on to shareholding structures...

The promoters of ALEMBIC PHARMA hold a 69.6% stake in the company. In case of Aurobindo Pharma the stake stands at 51.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALEMBIC PHARMA and the shareholding pattern of Aurobindo Pharma.

Finally, a word on dividends...

In the most recent financial year, ALEMBIC PHARMA paid a dividend of Rs 10.0 per share. This amounted to a Dividend Payout ratio of 38.1%.

Aurobindo Pharma paid Rs 9.0, and its dividend payout ratio stood at 19.7%.

You may visit here to review the dividend history of ALEMBIC PHARMA, and the dividend history of Aurobindo Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Snaps 4-Day Losing Streak, Gains 160 Points | Bank Nifty Gains 1% to Hit Record High | PSU Bank Stocks Rally(Closing)

After opening the day on a flat note, Indian share markets extended gains during the last hour of trade to end higher.